1. The quantification of alantitrypsin (alAT) by standard immunological techniques is altered by interaction of the protein with leucocyte elastase.
Introduction
Proteolytic enzymes have been implicated in the pathogenesis of several acute and chronic lung diseases including emphysema [ 11, the adult respiratory distress syndrome [2] , bronchiectasis [3] and cystic fibrosis [4] . However, the secretions contain several enzyme inhibitors which protect the lung from enzyme induced damage. The exact mechanisms whereby the enzymes can overcome this protective inhibitor 'screen' are poorly understood but it has been suggested that a defect in the 'screen' as a result of a decrease in the function of the inhibitors may be important.
al-Antitrypsin (al-proteinase inhibitor) is a major enzyme inhibitor of lung secretions and has so far received most attention. Evidence has shown that this inhibitor can be present not only in its native (active) form but also as an enzyme-inhibitor complex [S] , in a partially proteolysed form [6] and in an oxidized form [7] . All these changes to the native qantitrypsin (alAT) are associated with loss of inhibitory function and would account for a reduction in its inhibitory capacity in the lung secretions, which may partly explain the susceptibility of some individuals to enzyme induced lung damage. However, the degree and therefore importance of any reduction in inhibitory capacity of the alAT depends largely upon the accuracy of its measurement.
Lung alAT is measured by conventional immunological techniques such as radial immunodiffusion [S] and rocket immunoelectrophoresis [ 9 ] , and compared with standard solutions of known alAT concentration. The accuracy of these techniques (coefficient of variation 4%) is entirely dependent upon physicochemical and immunological identity of the test protein and the standard solution [lo] . Therefore measurement of lung alAT that has been altered as described above may give inaccurate results when compared with a standard solution of the native (unaltered) protein.
Direct evidence of inaccuracies in the quantification of lung aIAT is lacking but can be implied from our previous data [5] . It is known that both alAT and albumin (proteins of almost identical size) are present in lung secretions largely as a result of simple diffusion from serum [ 1 11. Thus their relative concentrations in the secretions and serum should be identical. However, our previous studies have shown that sputum alAT is between 0.5 and 6 times the value expected in comparison with albumin [S] . In view of the accuracy of the immunological techniques employed, this suggests major over-and under-estimation of alAT in some samples.
There is currently no information concerning the effect of proteolysis, oxidation and complexing with enzyme upon the immunological measurement of alAT. The present study was designed to investigate this problem in vitro in order to determine what error (if any) might be expected in quantifying alAT in lung secretions.
Methods

Proteins
Leucocyte elastase (LE) was purified from circulating human polymorphs as described previously [12] and was kindly donated by Dr A. J. Barrett (Strangeways Laboratories, Cambridge). The protein was dissolved in Trislphosphate buffer (0.05 mol/l, pH 8.0) containing NaCl (0.2 mol/l) and Triton (0.1%). The concentration of LE was determined in a standard way from the absorbance at 280 nm (absorption coefficient = 9.85).
The enzyme activity was determined by active site titration, the method of Nakajima & Powers [13] being used with the chromogenic substrate N-succinyl trialanine p-nitroanilide. The elastase was found to retain 68% of the expected activity and this figure was used throughout the studies.
al-Antitrypsin was purified from human plasma. The (NH4)?S04 precipitated fraction was subjected t o chromatography on DEAE-Sephacel (Pharmacia) and eluted with an increasing salt gradient (0.05-0.5 mol/l Tris/HCl, pH 8.8). The fractions containing aIAT (identified immunologically with monospecific antisera) were then pooled and applied to a Sepharose concanavalin A affinity column (Pharmacia) and eluted with methylmannoside (0.05 mol/l in buffer, pH 6.0: 0.1 mol/l acetate, 1 mol/l NaC1, 1 mmol/l CaClz and 1 mmolll MgC12).
The remaining minor contaminant was identified immunologically as orosomucoid and this was removed by an immunoadsorbent column prepared from cyanogen bromide-activated Sepharose (Pharmacia) and the immunoglobulin fraction of a monospecific antiserum t o orosomucoid (Seward Laboratories).
The remaining protein was kept in 0.05 mol/l Tris/HCl buffer (pH 8.8). The concentration was assessed by rocket immunoelectrophoresis [9] and compared with the British standard reference serum 74/520 (1 700 mg/l).
Purity was assessed immunologically and the preparation was shown to produce only one peak on two-dimensional immunoelectrophoresis against anti-(whole human serum) (Seward Laboratories); in particular no cross-reactivity was shown with monospecific antiserum to the other serum proteinase inhibitors (a2-macroglobulin, al-antichymotrypsin inter*-trypsin inhibitor, C1 esterase inhibitor and antithrombin 111).
Sodium dodecyl sulphate (SDS)-polyacrylamide gel electrophoresis [14] gave two bands, the major one at a mol. wt. of 54000 and a minor one at 50 000, suggesting the presence of some alAT that had undergone limited proteolysis. The alAT activity was determined from its ability to inhibit the characterized LE.
The assays were performed by adding increasing amounts of the alAT to a fixed amount (4 pg) of LE in 0.5 ml of Tris/HCl buffer (0.2 mol/l, pH 8.8).
The mixtures were incubated for 10min (37'C), then 0.5 ml of the substrate (N-succinyl trialanine p-nitroanilide, 3 mg/ml) was added and incubation continued for a further 10min. The absorbance was then recorded at 410 nm and compared with that of a blank of substrate alone. A typical inhibition curve is shown in Fig. 1 . The two proteins are known to interact on a 1 : 1 molar basis and the intercept should occur through the point of functional equivalence. Assuming molecular weights of 30000 for LE [15] and 54 000 for alAT [ 161, as well as only 68% activity of the enzyme, it is possible to determine the activity of the alAT from the intercept. The alAT quantity for the intercept obtained was 1.45 times higher than expected for fully active alAT, suggesting 69.1% remaining inhibitory activity of the preparation.
For subsequent studies molar ratios of LE and alAT were taken from the functional inhibition curve shown in Fig 
Protein assessment
The immunological changes to alAT were assessed by standard rocket immunoelectrophoresis (RIEP) as described by Laurell [9] . In brief, aliquots of the LE/alAT reaction mixtures were placed in wells cut into a 1 mm thick agarose gel containing monospecific antisera to alAT. The plates were electrophoresed overnight (3 V/cm), then dried and pressed. After this the plates were stained with 2% kenacid blue and the heights of the precipitation arcs were measured and compared with fresh aliquots of the alAT used as a standard on each plate. A further control of alAT incubated alone at 37°C for the same length of time as the LE/alAT mixtures, and at the same concentraions as in the mixtures, was also included on each plate.
In some experiments the alAT in the reaction mixtures was compared with alAT alone by both RIEP .and radial immunodiffusion as described by Mancini et al. [8] .
The presence of alAT/LE complexes was confirmed by standard SDS-polyacrylamide gel electrophoresis [13] and the proportion of complexed alAT was assessed by two-dimensional immunoelectrophoresis (2DIEP) as described previously [5] . The presence of alAT that had undergone limited proteolysis was assessed by SDS-polyacrylamide gel electrophoresis alone.
Hydrogen peroxide (3%, w/v) was obtained from Thornton and Ross (Huddersfield) and amounts from 5 to 50pl were incubated with alAT (17.4pg of alAT in 504) for 30min at 37' C. The total loss of inhibitory activity against LE over 10min incubation was confirmed with the enzyme assay described above. The alAT was simultaneously assessed by RIEP as described above and compared with a control sample of alAT alone.
Antisera used
Three monospecific antisera to alAT were assessed. All were the immunoglobulin fraction of sheep antisera raised in the Immunodiagnostic Research Laboratory, University of Birmingham. Two of the antisera have been commercially available (Seward Laboratories).
Results
Effect of complexing and proteolysis
The interaction of a1AT and LE in the presence of excess inhibitor (LE/alAT molar ratio < 1 : 1) produced increasing enzyme-inhibitor complex (expressed as a proportion of total alAT) seen on 2DIEP with increasing amounts of LE added (Fig. 2) . The presence of these complexes was confirmed by SDS-polyacrylamide gel electrophoresis (data not shown).
The effect of this complexing upon the immunological assessment of alAT is shown as part of Figs. 3 and 4. After 10 min incubation of enzyme with inhibitor there was a progressive diminution in the quantification of alAT immunologically as the functional molar ratio of LE/alAT increased and the proportion of enzyme-inhibitor complex increased. The average value at molar ratio 0.75 : 1 (LE: alAT), when about 60% of the alAT was present as enzyme-inhibitor complex, was 74.5% (SD k 2.61; n = 6) of that obtained for alAT alone. The value obtained at functional molar equivalence, 1 : 1 (LE/alAT), when 69% of the alAT was present as complex, was 89.7% (SD f 5.7) of the control value.
However, this reduction in alAT quantification was short-lived and by 6 h incubation the results obtained in inhibitor excess had returned to the control values (Fig. 4) , although the aIAT value for functional equivalence (1 : 1 molar ratio) was now found to exceed the control value (" 130%). Over the subsequent 24-48h the a1AT values obtained for these mixtures showed a continued showed that although enzyme-inhibitor complexes were formed initially the proportion of alAT present as complex was slightly less at 10 min [61.8%*4.4 for molar ratio 2: 1 (LE/aIAT) and 55.9% * 3.6 for 3 : l ; n = 31 than seen at functional molar equivalence, suggesting some early breakdown of the complex. This was associated with alAT measurements nearer to the control value (Fig. 3) . However, with longer periods of incubation the enzyme-inhibitor complexes formed in the presence of excess enzyme showed more rapid disappearance as seen on both 2DIEP and SDSpolyacrylamide gel electrophoresis than samples in inhibitor excess. These results are being reported in detail elsewhere but after 6 h incubation the concentration value obtained for alAT in the presence of excess enzyme had risen to about 150% of the control value. A continued rise in quantification was again seen over the next 24-48 h, reaching more than 300% of the control value (Fig. 4) , and this was associated with no enzymeinhibitor complexes seen on 2DIEP or SDS-polyacrylamide gel electrophoresis and only the presence of partially proteolysed alAT (mol. wt. Y 50 000) demonstrated by the latter technique. Photographs of RIEP plates from one such experiment are shown in Fig. 5 . The precipitation rockets for all samples are well formed and similar to those for the standard and control samples of alAT. Furthermore the results obtained by this technique were similar to those obtained by conventional radial immunodiffusion [ 8 ] , suggesting that the immunological changes observed are not confined to immunoelectrophoresis (data not shown). Table 1 . One antiserum (2820) gave results very close to the control value for all samples, whereas the others gave results up to 200% of the control value (2567).
Effect of different antisera
Photographs of the rocket plates are shown in Fig. 7 for the two antisera giving the results closest to and furthest from the control value. The rockets showing most change from the control value (antiserum 2567 functional equivalence and enzyme excess) also appear less distinct. These differences between antisera were more pronounced after 2 4 h and are summarized in Fig. 8 .
Effect of oxidation
The addition of Hz02 solution for 30min resulted in complete loss of inhibitory function against LE, as shown by the method described previously, even when only 5 pl was added to 17.4 pg of alAT in 50 p1 of buffer. Despite this, immunological changes were minimal until larger quantities of H202 were added (Fig. 9) . standard immunological techniques comparing the secretion with a known reference sample. However, in the secretion alAT is often exposed t o many factors including enzymes and oxidants within the lung for various times before sampling. Furthermore the standard alAT with which these samples are quantified is usually a reference serum or pure native protein. Unless the antibody used is directed against antigenic determinants on the alAT molecule which are unaltered by such factors in the lung the result is likely to be inaccurate.
The present studies confirm that interaction of alAT with enzymes can lead to major errors in estimating the protein immunologically. The interaction of alAT and LE in the presence of excess alAT leads to the formation of enzyme-inhibitor complexes demonstrable by both 2DIEP and SDSpolyacrylamide electrophoresis. This is associated with a rapid but small (up to 25%) underestimation of the alAT immunologically. However, over the next 4-6 h the result obtained returned to the expected value even for the antiserum, which was thought to be least satisfactory (Fig. 4) . Over the subsequent 24-48 h further assessment of the aIAT/LE mixtures resulted in more significant overestimation of the q A T , with results up to twofold greater than expected (Fig. 4) , and this was associated with a breakdown of the complex seen on 2DIEP.
The results obtained at molar equivalence and in the presence of enzyme excess when none of the alAT is functionally active were different from those in inhibitor excess. measurement of alAT even with the least satisfactory antiserum (Fig. 4) . However, with the more rapid breakdown of enzyme-inhibitor complexes seen on 2DIEP and the appearance of more inactive alAT that had undergone limited proteolysis (confirmed by SDS-polyacrylamide gel electrophoresis), major overestimation of the alAT occurred and this increased from 1.5 times the control value after 6 h to almost threefold after 48 h.
Three different antisera were tested and the result obtained for each alAT/LE interaction mixture was dependent upon which one was used (Table 1 and Fig. 6 ). One of the antisera (2820) was much better than the other two for assessing the altered q A T (i.e. the results obtained were closer to the control value). This antiserum gave the results close to the control value for a l l alAT/ LE mixtures over the. fust 6 h of incubation, though it still overestimated the alAT in the mixtures of 2 4 h by 1.3-1.8 times the control value, depending on the molar ratio of the alAT/LE mixtures (Fig. 8) .
The results suggest that the native, complexed and partially proteolysed forms of alAT all react differently in immunological assays. When native alAT is used as a standard the value for a secretion alAT will be slightly low for recently formed complex and high for the partially proteolysed form. The actual result obtained will vary depending on the relative proportions of these components, which in itself will depend upon how recently the complexes have been formed (i.e. how much degradation of the complex to the partially proteolysed form of alAT has occurred).
In general the results obtained in the presence of excess alAT (where some functional inhibitory activity would remain) tend to be relatively accurate for up to 6 h after interaction with enzyme. On the other hand, samples in excess enzyme (where no functional inhibitory activity would remain) tend to give up to a 1.5-fold overestimation of the alAT concentration within 6 h.
The results obtained for different antisera are of major importance. All gave a different result for the same sample and often the immunoprecipitate was indistinguishable from the native protein. This may not be of importance when assessing alAT function in lung secretions where excess enzyme is present since no inhibitory activity would remain. However, it is of major importance when comparing alAT concentrations in lung secretions from different patients where the proportions present as native, complexed and proteolysed alAT vary, and when assessing the alAT function in secretions where inhibitory activity persists. The results from these latter studies will not only be dependent upon the varying proportions of alAT inactive due to enzyme-inhibitor complexes or proteolysis, but also the source and batch of antisera used. Furthermore, even when relatively accurate and well-characterized antisera are used, such as the one studied here (Z820), the results are likely to be accurate only if the alAT has been present in the lung and exposed t o enzyme for less than 6 h. This in itself may depend upon whether bronchial or alveolar secretions are studied or whether they are collected during the day or after an overnight sleep.
On the other hand total inactivation of alAT by an oxidant (H202) produced very little immunological change until it was present in quantities well exceeding the damaging threshold. This is in contradiction to recent studies with cigarette smoke solution, which results in significant immunological changes to alAT even when it is only partially inactivated [ 171. The current results would suggest that the immunological changes due to cigarette smoke are independent of the oxidant effect which inactivates the alAT [ 181.
The relevance of such immunological changes in attempts to understand the pathogenesis of diseases such as emphysema may seem uncertain. However, although it is generally accepted that emphysema develops in subjects who have functional alAT in the alveoli decreased by about 60% [ 191, factors which produce such a change are uncertain and thus possible preventive measures cannot be considered (unless subjects who smoke can be persuaded otherwise). The only study assessing lung alAT function in smokers is that of Gadek ef al. [20] , who found only a 40% reduction in lung alAT function. This was thought t o be the result of oxidation of the alAT, and the present study with the antisera used here suggests that if the reduction in inhibitory activity is due to oxidation the alAT measurement and hence the degree of inactivation is probably correct.
Overcoming such problems is likely to be necessary if the major determinants of proteolytic lung diseases are to be identified. There remain several alternative approaches. Firstly, knowing the serum quantities of alAT and albumin and the secretion value for albumin it may be possible to assume the expected value of alAT in the secretion, although this is dependent upon similar catabolism of both proteins in the lung. Secondly, a more satisfactory solution will be t o measure the alAT directly with antiserum that detects only antigenic determinants that remain unaltered in the secretions. This latter approach may require the development of monoclonal antiserum and until then all results from different centres may not be comparable.
In conclusion antigenic alteration of alAT in the lung secretions may lead to major errors in its estimation. This indicates that without wellcharacterized antiserum the results of quantitative and functional assessment of lung q A T and comparison between laboratories should be viewed with caution.
